Answers are grounded in this paper and cite their sources.
Identifies novel biomarkers for pancreatic ductal adenocarcinoma, suggesting new drug candidates.
were identified as hub genes and demonstrated significant survival probability for PDAC. In addition to providing novel biomarkers for diagnosis that can be detected non-invasively, the secretion levels of hub genes-associated proteins were found in plasma, serum, and oral epithelium. The drug repositioning analysis revealed vorinostat, meclocycline sulfosalicylate, and trichostatin A, which exhibited significant binding affinities to the hub genes compared to their inhibitors via molecular docking analysis.
No takes yet. Share an insight, caveat, or question.
Aydın et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: